Matches in Wikidata for { <http://www.wikidata.org/entity/Q37292166> ?p ?o ?g. }
- Q37292166 description "article científic" @default.
- Q37292166 description "article scientifique" @default.
- Q37292166 description "articolo scientifico" @default.
- Q37292166 description "artigo científico" @default.
- Q37292166 description "artículu científicu espublizáu en 2009" @default.
- Q37292166 description "bilimsel makale" @default.
- Q37292166 description "scientific article published on June 2009" @default.
- Q37292166 description "vedecký článok" @default.
- Q37292166 description "vetenskaplig artikel" @default.
- Q37292166 description "videnskabelig artikel" @default.
- Q37292166 description "vědecký článek" @default.
- Q37292166 description "wetenschappelijk artikel" @default.
- Q37292166 description "wissenschaftlicher Artikel" @default.
- Q37292166 description "наукова стаття, опублікована в червні 2009" @default.
- Q37292166 description "научни чланак" @default.
- Q37292166 description "مقالة علمية نشرت في يونيو 2009" @default.
- Q37292166 name "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 name "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 name "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 type Item @default.
- Q37292166 label "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 label "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 label "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 prefLabel "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 prefLabel "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 prefLabel "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." @default.
- Q37292166 P1433 Q37292166-9ABE4B38-1AED-475C-AE63-B5EBCD583633 @default.
- Q37292166 P1476 Q37292166-3F8450CE-6505-4540-83FE-875E9820968F @default.
- Q37292166 P2093 Q37292166-06732D40-7E7F-46F3-A215-2B502CE86492 @default.
- Q37292166 P2093 Q37292166-223AF67D-71EA-41A3-A6CE-98A8B841B6CB @default.
- Q37292166 P2093 Q37292166-6431843E-BBE1-4D8B-9D74-26D0A250918D @default.
- Q37292166 P2093 Q37292166-77FB9ABE-51BA-4ED6-88DF-3C5AF6D9E8B4 @default.
- Q37292166 P2093 Q37292166-8CC85BD7-6419-4258-A2AF-A9CF930D15D5 @default.
- Q37292166 P2093 Q37292166-D4108722-6A37-4598-87A3-90E5D0D30785 @default.
- Q37292166 P2093 Q37292166-FECC8D7F-1A1A-46D3-A38C-7FB8576AB0A8 @default.
- Q37292166 P2860 Q37292166-0CD0B22C-C6E8-4B4B-8C23-B27CBE454406 @default.
- Q37292166 P2860 Q37292166-0F5D713A-9E2C-4DED-9570-BD72D66CCFBA @default.
- Q37292166 P2860 Q37292166-1B9873FA-6230-4A04-87E6-E17E5CE1447D @default.
- Q37292166 P2860 Q37292166-3C34B071-B9B4-42E9-9B7F-194A905F9CAE @default.
- Q37292166 P2860 Q37292166-60C9A849-EC25-47AC-9A89-92588A79DA39 @default.
- Q37292166 P2860 Q37292166-61AB2F0A-919B-42D9-BA6E-823A380D1A5B @default.
- Q37292166 P2860 Q37292166-7320256B-E996-4146-9EDC-400131AD578E @default.
- Q37292166 P2860 Q37292166-7CE90152-35C9-4D6F-B701-BB4F1AD8C331 @default.
- Q37292166 P2860 Q37292166-806BEB80-0AEA-4F14-9393-8747FF8D8280 @default.
- Q37292166 P2860 Q37292166-82FA67C4-AFA0-4F26-8F93-3ABE1BAEC261 @default.
- Q37292166 P2860 Q37292166-8E2C513C-DA62-44FE-9DD7-11C0636383FE @default.
- Q37292166 P2860 Q37292166-912D8B48-F6EB-4969-B3FC-DDBC84E6B7C4 @default.
- Q37292166 P2860 Q37292166-92729C64-33DC-43F7-AF97-EFF780AA681F @default.
- Q37292166 P2860 Q37292166-956BDA39-91BC-4BAB-92D8-F540C31A5C9A @default.
- Q37292166 P2860 Q37292166-96568BB5-4D96-4BF1-80EF-2257CB7687DD @default.
- Q37292166 P2860 Q37292166-9B3F0787-6F42-4505-B260-9CED1F353A34 @default.
- Q37292166 P2860 Q37292166-A2D8C713-DCAF-4690-99C3-BA2E636A2808 @default.
- Q37292166 P2860 Q37292166-B23E6239-EDF0-4673-8854-D006A58B0284 @default.
- Q37292166 P2860 Q37292166-BECC0833-9201-4F6B-9740-F0C9BAF771DF @default.
- Q37292166 P2860 Q37292166-E8870E39-51A2-4146-977A-96BC4F7C628E @default.
- Q37292166 P304 Q37292166-22A9ED9B-568D-47CA-B6A8-AEB6B5489F41 @default.
- Q37292166 P31 Q37292166-BEB1DA63-2937-4CDB-89B3-01BF70F550B1 @default.
- Q37292166 P356 Q37292166-6B0AC665-D6DC-4544-BB0D-8258B6E001CC @default.
- Q37292166 P407 Q37292166-B4040423-3CF2-4EB2-8F6E-5755F73696D6 @default.
- Q37292166 P433 Q37292166-45582B6C-EF92-49AE-8D85-CBF525C42082 @default.
- Q37292166 P478 Q37292166-D4444E67-71F6-464F-BECC-327771000521 @default.
- Q37292166 P50 Q37292166-7F5B2A91-74FC-4FB5-93A5-A3AE3328A966 @default.
- Q37292166 P50 Q37292166-CB56F6CD-9D57-4150-BE89-4E8E4EA8E9E7 @default.
- Q37292166 P577 Q37292166-F2D68746-DFE7-4441-9606-C81501C4F797 @default.
- Q37292166 P698 Q37292166-97C690C3-AAA5-4A00-BEFB-30D18713249A @default.
- Q37292166 P921 Q37292166-D07F3280-3132-4A85-B2F6-9E0CB6B9BAFB @default.
- Q37292166 P932 Q37292166-A59B429F-50B4-444B-8233-30D7C9A5B93F @default.
- Q37292166 P356 J.1753-5174.2008.00015.X @default.
- Q37292166 P698 19684847 @default.
- Q37292166 P1433 Q15753799 @default.
- Q37292166 P1476 "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results" @default.
- Q37292166 P2093 "Duma Khutsoane" @default.
- Q37292166 P2093 "Majeed Almustafa" @default.
- Q37292166 P2093 "Ole Molskov Bech" @default.
- Q37292166 P2093 "Rucsandra Danciulescu" @default.
- Q37292166 P2093 "Sami Azar" @default.
- Q37292166 P2093 "Serdar Güler" @default.
- Q37292166 P2093 "Surendra Kumar Sharma" @default.
- Q37292166 P2860 Q24246084 @default.
- Q37292166 P2860 Q27860882 @default.
- Q37292166 P2860 Q31033684 @default.
- Q37292166 P2860 Q33864120 @default.
- Q37292166 P2860 Q33984638 @default.
- Q37292166 P2860 Q34542859 @default.
- Q37292166 P2860 Q36549321 @default.
- Q37292166 P2860 Q42676804 @default.
- Q37292166 P2860 Q43869405 @default.
- Q37292166 P2860 Q44655656 @default.
- Q37292166 P2860 Q44746359 @default.
- Q37292166 P2860 Q46758021 @default.
- Q37292166 P2860 Q46860926 @default.
- Q37292166 P2860 Q46883811 @default.
- Q37292166 P2860 Q51626419 @default.
- Q37292166 P2860 Q53254408 @default.
- Q37292166 P2860 Q57232788 @default.
- Q37292166 P2860 Q73014285 @default.
- Q37292166 P2860 Q77608955 @default.
- Q37292166 P2860 Q81312983 @default.
- Q37292166 P304 "23-33" @default.
- Q37292166 P31 Q13442814 @default.